Page last updated: 2024-10-29

ketamine and Reperfusion Injury

ketamine has been researched along with Reperfusion Injury in 46 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research Excerpts

ExcerptRelevanceReference
"The primary aim of this study was to compare the effects of a small-dose infusion of 2 antioxidant agents, ketamine and lidocaine, on ischemia-reperfusion injury (IRI) in patients undergoing elective lower limb surgery."9.30The effects of ketamine and lidocaine on free radical production after tourniquet-induced ischemia-reperfusion injury in adults. ( Deyişli, C; Kıyıcı, A; Ökesli, S; Peker, K, 2019)
"To determine the effects of a small-dose ketamine-propofol combination used for sedation during spinal anesthesia on tourniquet-induced ischemia-reperfusion injury."9.19The effects of a small-dose ketamine-propofol combination on tourniquet-induced ischemia-reperfusion injury during arthroscopic knee surgery. ( Akan, B; Baydar, M; Bayrakci, S; Girgin, G; Gogus, N, 2014)
"Male Sprague Dawley rats received a CO2 pneumoperitoneum of 15 mmHg and preceded by either low-dose ketamine (KP1, 5 mg/kg; KP2, 10 mg/kg) or 0."7.80Low-dose ketamine pretreatment reduces oxidative damage and inflammatory response following CO2 pneumoperitoneum in rats. ( Bowen, D; Jieshou, L; Ning, L; Peng, Z; Tao, F; Wu, J; Xiaoming, K; Xin, G; Xingwei, X, 2014)
"Low-dose ketamine preconditioning can reduce the inflammatory reaction and lessen oxidative damage in the intestinal mucosa following pneumoperitoneum in rats."7.79[Protective effect of low-dose ketamine against intestinal ischemia-reperfusion injury following carbon dioxide pneumoperitoneum in rats]. ( Tian, F; Wang, W; Yan, L, 2013)
"To investigate blood creatinine and renal histology in rats anesthetized with S(+)-ketamine (keta) or dexmedetomidine (dex) and submitted to kidney ischemia/reperfusion injury (IRI)."7.77Dexmedetomidine and S(+)-ketamine in ischemia and reperfusion injury in the rat kidney. ( Braz, JR; Castiglia, YM; Curtis, FG; Fiorio, PM; Oliveira, C; Silva, LM; Vianna, PT; Viero, RM, 2011)
"To investigate the effects of ketamine pretreatment on cerebral edema following brain ischemia reperfusion injury in rats and assess the involvement of Aquaporin 4 (AQP4) expression."7.76[The effects of ketamine pretreated on cerebral edema and AQP4 expression after transient focal cerebral ischemia/reperfusion in rats]. ( Cai, SN; Zhu, SM, 2010)
"To determine if the inhibitory effects of ketamine on the extracellular signal-regulated kinase (ERK) 1/2 are involved in reduction of the hyperglycemia-exaggerated cerebral ischemic lesion, rats with normoglycemia, hyperglycemia, or hyperglycemia supplemented with ketamine were subjected to 15 min of forebrain ischemia, and then, reperfusion for 0."7.74Inhibitory effect of ketamine on phosphorylation of the extracellular signal-regulated kinase 1/2 following brain ischemia and reperfusion in rats with hyperglycemia. ( Guo, FY; Jing, L; Ma, Y; Wang, YL; Zhang, JZ, 2007)
"Ketamine was able to diminish alterations induced by I/R."5.36Ketamine and the myenteric plexus in intestinal ischemia/reperfusion injury. ( Alarcón-Galván, G; Ballesteros-Elizondo, RG; Cámara-Lemarroy, CR; Cordero-Pérez, P; Fernández-Garza, NE; Guzmán-de la Garza, FJ, 2010)
"Ketamine pretreatment was administered by intraperitoneal injections at doses of 100, 50, 12."5.36Ketamine reduces intestinal injury and inflammatory cell infiltration after ischemia/reperfusion in rats. ( Alarcón-Galván, G; Ballesteros-Elizondo, RG; Cámara-Lemarroy, CR; Cordero-Pérez, P; Fernández-Garza, NE; Guzmán-De La Garza, FJ, 2010)
"After cerebral ischemia/reperfusion, the relative protein concentration of Bax was increased by 110% in control animals compared with the dexmedetomidine- and S(+)-ketamine-treated rats and by 140% compared with the sham-operated animals."5.32The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. ( Bachl, M; Blobner, M; Eberspächer, E; Engelhard, K; Hildt, E; Hutzler, P; Kochs, E; Werner, C, 2003)
"The primary aim of this study was to compare the effects of a small-dose infusion of 2 antioxidant agents, ketamine and lidocaine, on ischemia-reperfusion injury (IRI) in patients undergoing elective lower limb surgery."5.30The effects of ketamine and lidocaine on free radical production after tourniquet-induced ischemia-reperfusion injury in adults. ( Deyişli, C; Kıyıcı, A; Ökesli, S; Peker, K, 2019)
"To determine the effects of a small-dose ketamine-propofol combination used for sedation during spinal anesthesia on tourniquet-induced ischemia-reperfusion injury."5.19The effects of a small-dose ketamine-propofol combination on tourniquet-induced ischemia-reperfusion injury during arthroscopic knee surgery. ( Akan, B; Baydar, M; Bayrakci, S; Girgin, G; Gogus, N, 2014)
"Male Sprague Dawley rats received a CO2 pneumoperitoneum of 15 mmHg and preceded by either low-dose ketamine (KP1, 5 mg/kg; KP2, 10 mg/kg) or 0."3.80Low-dose ketamine pretreatment reduces oxidative damage and inflammatory response following CO2 pneumoperitoneum in rats. ( Bowen, D; Jieshou, L; Ning, L; Peng, Z; Tao, F; Wu, J; Xiaoming, K; Xin, G; Xingwei, X, 2014)
"Low-dose ketamine preconditioning can reduce the inflammatory reaction and lessen oxidative damage in the intestinal mucosa following pneumoperitoneum in rats."3.79[Protective effect of low-dose ketamine against intestinal ischemia-reperfusion injury following carbon dioxide pneumoperitoneum in rats]. ( Tian, F; Wang, W; Yan, L, 2013)
"To investigate blood creatinine and renal histology in rats anesthetized with S(+)-ketamine (keta) or dexmedetomidine (dex) and submitted to kidney ischemia/reperfusion injury (IRI)."3.77Dexmedetomidine and S(+)-ketamine in ischemia and reperfusion injury in the rat kidney. ( Braz, JR; Castiglia, YM; Curtis, FG; Fiorio, PM; Oliveira, C; Silva, LM; Vianna, PT; Viero, RM, 2011)
"5 mg/kg ketamine pretreatment showed significant protective effect on acute lung injury induced by HIR, which might be mediated by the NF-κB pathway."3.77A single small dose of ketamine prevents lung injury following hepatic ischemia-reperfusion in rabbits. ( Jin, L; Shen, H; Zhou, Y; Zhuang, X, 2011)
"To investigate the effects of ketamine pretreatment on cerebral edema following brain ischemia reperfusion injury in rats and assess the involvement of Aquaporin 4 (AQP4) expression."3.76[The effects of ketamine pretreated on cerebral edema and AQP4 expression after transient focal cerebral ischemia/reperfusion in rats]. ( Cai, SN; Zhu, SM, 2010)
"To determine if the inhibitory effects of ketamine on the extracellular signal-regulated kinase (ERK) 1/2 are involved in reduction of the hyperglycemia-exaggerated cerebral ischemic lesion, rats with normoglycemia, hyperglycemia, or hyperglycemia supplemented with ketamine were subjected to 15 min of forebrain ischemia, and then, reperfusion for 0."3.74Inhibitory effect of ketamine on phosphorylation of the extracellular signal-regulated kinase 1/2 following brain ischemia and reperfusion in rats with hyperglycemia. ( Guo, FY; Jing, L; Ma, Y; Wang, YL; Zhang, JZ, 2007)
"The aim of this study was to investigate any possible protective effect of ketamine in acute muscular ischaemia and reperfusion injury by measuring malondialdehyde using thiobarbituric acid assay in rats."3.73The effect of ketamine on acute muscular ischaemia reperfusion in rats. ( Aypar, U; Dal, D; Iskit, AB; Salman, AE; Salman, MA, 2005)
" Pretreatment with N-methyl-D-aspartate (NMDA) receptor antagonist ketamine, non-NMDA receptor antagonist DNQX, or NF-kappaB inhibitor PDTC decreased the IKK activity following brain ischemia 30 min."3.72Modulation of IkappaB kinase autophosphorylation and activity following brain ischemia. ( Shen, WH; Zhang, CY; Zhang, GY, 2003)
"The effects of three drugs including ketamine(KT), a noncompetitive antagonist of NMDA receptor (NR), nifedipine(ND), a voltage gated calcium channel (VGCC) antagonist and 6, 7dinitroquinoxaline -2, 3-dione(DNQX), a non-NMDA receptor antagonist on the contents of phospho-tyrosine proteins (p-tyr-pr) in the synaptosomal(P2), the crude membrane (P3), and the cytosolic (S3) fractions of hippocampus in forebrain ischemia of mongolian gerbils were studied."3.71[Effects of ischemia/reperfusion on the phosphotyrosine proteins contents in hippocampus]. ( Gui, ZH; Li, Y; Pei, L; Zhang, GY; Zhu, ZM, 2001)
" To evaluate the role played by NMDA antagonists in ischemia-reperfusion injury of the cochlea, 3 noncompetitive NMDA antagonists--ketamine, dextromethorphan, and MK-801--were administered to 53 albino guinea pigs subjected to transient ischemia of 30 minutes' duration, and the threshold shifts of the compound action potential were compared with those of nontreated animals 4 hours after the onset of recirculation."3.71Effect of ketamine, dextromethorphan, and MK-801 on cochlear dysfunction induced by transient ischemia. ( Hara, A; Ito, Z; Kusakari, J; Tabuchi, K; Tsuji, S; Wada, T, 2002)
"Ketamine has proposed anti-inflammatory effects and has been used for treating CRPS."1.42Preventive Treatment with Ketamine Attenuates the Ischaemia-Reperfusion Response in a Chronic Postischaemia Pain Model. ( Cheung, CW; Choi, SW; Irwin, M; Liman, S; Ng, KF; Qiu, Q; Tai, W; Wong, KL, 2015)
"Acute kidney injury is associated with the activation of NMDA receptors, as well as significant oxidative stress."1.39Effect of modulating the allosteric sites of N-methyl-D-aspartate receptors in ischemia-reperfusion induced acute kidney injury. ( Arora, S; Kaur, T; Pundir, M; Singh, AP; Singh, R, 2013)
"Mannitol flux was greater in ischemic tissues than in reperfused tissues."1.37In vitro and in vivo responses of mucosa from the large colon of horses to ischemia and reperfusion. ( Freeman, DE; Graham, AS; Grosche, A; Morton, AJ; Polyak, MM, 2011)
"Ketamine was able to diminish alterations induced by I/R."1.36Ketamine and the myenteric plexus in intestinal ischemia/reperfusion injury. ( Alarcón-Galván, G; Ballesteros-Elizondo, RG; Cámara-Lemarroy, CR; Cordero-Pérez, P; Fernández-Garza, NE; Guzmán-de la Garza, FJ, 2010)
"Ketamine pretreatment was administered by intraperitoneal injections at doses of 100, 50, 12."1.36Ketamine reduces intestinal injury and inflammatory cell infiltration after ischemia/reperfusion in rats. ( Alarcón-Galván, G; Ballesteros-Elizondo, RG; Cámara-Lemarroy, CR; Cordero-Pérez, P; Fernández-Garza, NE; Guzmán-De La Garza, FJ, 2010)
"After cerebral ischemia/reperfusion, the relative protein concentration of Bax was increased by 110% in control animals compared with the dexmedetomidine- and S(+)-ketamine-treated rats and by 140% compared with the sham-operated animals."1.32The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. ( Bachl, M; Blobner, M; Eberspächer, E; Engelhard, K; Hildt, E; Hutzler, P; Kochs, E; Werner, C, 2003)
"Halothane alone was of no benefit."1.28Protecting the ischemic spinal cord during aortic clamping. The influence of anesthetics and hypothermia. ( Facundus, EC; Hollier, LH; Money, SR; Naslund, TC; Skenderis, BS, 1992)

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (8.70)18.2507
2000's18 (39.13)29.6817
2010's21 (45.65)24.3611
2020's3 (6.52)2.80

Authors

AuthorsStudies
Verney, C1
Legouis, D1
Placier, S1
Migeon, T1
Bonnin, P1
Buob, D1
Hadchouel, J1
Galichon, P1
Zhu, L2
Zhang, Y7
Chen, G1
Kamat, PK1
Ahmad, AS1
Doré, S1
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Zhao, Y3
Wang, J7
Huang, L2
Hu, K1
Liu, H4
Wang, H3
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Wang, B4
Zhang, Q4
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Wang, W3
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X4
Yao, LP1
Qin, QP1
Wang, ZY1
Liu, J4
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H1
He, C2
Xiao, Z1
Xu, J2
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Li, X5
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Liu, Z3
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Zhang, X6
Xu, N1
Wang, R1
Liu, S1
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Han, J2
Zhang, C5
Chen, L2
Yang, X1
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H4
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Wang, C3
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y8
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Li, L4
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X1
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Li, J8
Du, S1
Zhou, H1
Cui, J1
Wu, W1
Liu, Y9
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Wu, Y2
Zhang, H1
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L1
Wang, L3
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X1
Dai, T1
Yang, Y3
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Li, Y8
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y2
Tang, J3
Chen, Z2
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z3
Qiu, N1
Yin, J1
Zhang, J3
Guo, W1
Liu, M2
Liu, T2
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Zhang, S2
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C1
Liu, C2
Liu, W1
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P1
Atyah, M1
Ma, Q2
Xu, Y1
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X3
Cao, Q1
Yuan, X1
Nie, W1
Yang, J3
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Zhang, L3
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Li, C2
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Liu, Q2
Liu, X3
Huang, Y2
Josephine Fauci, A1
Ma, Y2
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Zhu, Y1
Yu, J1
Tian, J1
Zhao, M1
Hu, J1
Yao, C1
Zhang, B1
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL2
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Shen, Y1
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z1
Li, Z2
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W2
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y4
Xue, H1
Zhang, W1
Ruan, Z1
Li, S2
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z2
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J1
Zhang, M1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S1
Luo, M1
Wu, J2
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Chen, J2
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G5
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D1
Hu, M1
Shen, H2
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C2
Sun, X1
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Ge, M1
Chen, C1
Zhou, S1
Huang, F1
Cai, J1
Hei, Z1
Song, X1
Wu, H1
Guo, P1
Jin, Z1
Tang, C1
Peker, K1
Ökesli, S1
Kıyıcı, A1
Deyişli, C1
Pundir, M1
Arora, S1
Kaur, T1
Singh, R1
Singh, AP1
Tian, F1
Yan, L1
Gogus, N1
Akan, B1
Bayrakci, S1
Girgin, G1
Baydar, M1
Xingwei, X1
Xin, G1
Peng, Z1
Tao, F1
Bowen, D1
Xiaoming, K1
Ning, L1
Jieshou, L1
Liman, S1
Cheung, CW1
Wong, KL1
Tai, W1
Qiu, Q1
Ng, KF1
Choi, SW1
Irwin, M1
de Resende, MA1
Pantoja, AV1
Barcellos, BM1
Reis, EP1
Consolo, TD1
Módolo, RP1
Domingues, MA1
Assad, AR1
Cavalcanti, IL1
Castiglia, YM2
Módolo, NS1
Cámara, CR1
Guzmán, FJ1
Barrera, EA1
Cabello, AJ1
Garcia, A1
Fernández, NE1
Caballero, E1
Ancer, J1
Yu, QJ1
Zhou, QS1
Huang, HB1
Wan, YL1
Tian, SF1
Duan, DM1
Hudetz, JA1
Pagel, PS1
Ergün, Y2
Darendeli, S2
Imrek, S1
Kilinç, M2
Oksüz, H3
Cámara-Lemarroy, CR3
Guzmán-de la Garza, FJ3
Alarcón-Galván, G3
Cordero-Pérez, P3
Fernández-Garza, NE3
Ballesteros-Elizondo, RG2
Atli, Y1
Dogan, Z1
Yuzbasioglu, MF1
Kurutas, EB1
Yildiz, H1
Coskuner, I1
Senoglu, N1
Bülbüloglu, E1
Cai, SN1
Zhu, SM1
Pei, L5
Zhang, GY5
Gui, ZH1
Zhu, ZM3
Curtis, FG1
Vianna, PT1
Viero, RM1
Fiorio, PM1
Silva, LM1
Braz, JR1
Oliveira, C1
Graham, AS1
Grosche, A1
Morton, AJ1
Polyak, MM1
Freeman, DE1
Jin, L1
Zhuang, X1
Oxburgh, L1
de Caestecker, MP1
Shen, W2
Engelhard, K1
Werner, C1
Eberspächer, E1
Bachl, M1
Blobner, M1
Hildt, E1
Hutzler, P1
Kochs, E1
Shen, WH1
Zhang, CY1
Zhang, PB1
Chen, XL1
Tian, YF1
Sun, JJ1
Liu, JX1
Saricaoglu, F1
Dal, D2
Salman, AE2
Doral, MN1
Klnç, K1
Aypar, Ü2
Salman, MA1
Iskit, AB1
Zhang, JZ1
Jing, L1
Guo, FY1
Renis, M1
Di Giacomo, C1
Sorrenti, V1
Russo, A1
La Delfa, C1
Reale, S1
Barcellona, ML1
Vanella, A1
Zong, Y1
Hou, X1
Cui, ZC2
Yan, JZ1
Tabuchi, K1
Tsuji, S1
Wada, T1
Ito, Z1
Hara, A1
Kusakari, J1
Chang, ML1
Kem, S1
Klaidman, L1
Sugawara, T1
Chan, PH1
Adams, JD1
Naslund, TC1
Hollier, LH1
Money, SR1
Facundus, EC1
Skenderis, BS1
Zhou, M1
Ma, T1
Tseng, MT1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of Ketamine Versus Sufentanil on Cerebral Glutamate After Traumatic Brain Injury : a Randomized, Double-blinded, Microdialysis Study[NCT02232347]Phase 220 participants (Anticipated)Interventional2014-10-31Not yet recruiting
Changes of the Short Portable Mental Status Questionnaire (SPMSQ-E) After Ketamine Administration on Ophthalmic Surgery in Geriatric Population.[NCT02049411]Phase 280 participants (Actual)Interventional2013-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for ketamine and Reperfusion Injury

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Neuroprotection by ketamine: a review of the experimental and clinical evidence.
    Journal of cardiothoracic and vascular anesthesia, 2010, Volume: 24, Issue:1

    Topics: Brain Ischemia; Cardiopulmonary Bypass; Cerebrovascular Circulation; Excitatory Amino Acid Antagonis

2010
Neuroprotection by ketamine: a review of the experimental and clinical evidence.
    Journal of cardiothoracic and vascular anesthesia, 2010, Volume: 24, Issue:1

    Topics: Brain Ischemia; Cardiopulmonary Bypass; Cerebrovascular Circulation; Excitatory Amino Acid Antagonis

2010
Neuroprotection by ketamine: a review of the experimental and clinical evidence.
    Journal of cardiothoracic and vascular anesthesia, 2010, Volume: 24, Issue:1

    Topics: Brain Ischemia; Cardiopulmonary Bypass; Cerebrovascular Circulation; Excitatory Amino Acid Antagonis

2010
Neuroprotection by ketamine: a review of the experimental and clinical evidence.
    Journal of cardiothoracic and vascular anesthesia, 2010, Volume: 24, Issue:1

    Topics: Brain Ischemia; Cardiopulmonary Bypass; Cerebrovascular Circulation; Excitatory Amino Acid Antagonis

2010

Trials

4 trials available for ketamine and Reperfusion Injury

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
The effects of ketamine and lidocaine on free radical production after tourniquet-induced ischemia-reperfusion injury in adults.
    Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 2019, Volume: 25, Issue:2

    Topics: Adult; Biomarkers; Free Radicals; Humans; Ketamine; Lactates; Lidocaine; Lower Extremity; Reperfusio

2019
The effects of a small-dose ketamine-propofol combination on tourniquet-induced ischemia-reperfusion injury during arthroscopic knee surgery.
    Journal of clinical anesthesia, 2014, Volume: 26, Issue:1

    Topics: Adult; Analgesics; Anesthesia, Spinal; Anesthetics, Combined; Anesthetics, Intravenous; Arthroscopy;

2014
Ketamine sedation during spinal anesthesia for arthroscopic knee surgery reduced the ischemia-reperfusion injury markers.
    Anesthesia and analgesia, 2005, Volume: 101, Issue:3

    Topics: Adult; Anesthesia, Spinal; Anesthetics, Dissociative; Anterior Cruciate Ligament; Arthroscopy; Bioma

2005

Other Studies

41 other studies available for ketamine and Reperfusion Injury

ArticleYear
Anaesthesia-Induced Transcriptomic Changes in the Context of Renal Ischemia Uncovered by the Use of a Novel Clamping Device.
    International journal of molecular sciences, 2021, Sep-11, Volume: 22, Issue:18

    Topics: Anesthesia; Animals; Disease Models, Animal; Ketamine; Kidney; Kidney Diseases; Male; Mice; Reperfus

2021
Discovery of novel ketamine-inspired derivatives as a protective agent against renal ischemic/reperfusion injury in Wistar rats.
    Chemical biology & drug design, 2022, Volume: 100, Issue:1

    Topics: Animals; Apoptosis; Ischemia; Ketamine; Kidney; NF-kappa B; Protective Agents; Rats; Rats, Wistar; R

2022
Distinctive effect of anesthetics on the effect of limb remote ischemic postconditioning following ischemic stroke.
    PloS one, 2020, Volume: 15, Issue:1

    Topics: Analgesics; Anesthetics; Animals; Brain Infarction; Brain Ischemia; Extremities; Halothane; Infarcti

2020
Overexpression of Brg1 Alleviates Hepatic Ischemia/Reperfusion-Induced Acute Lung Injury through Antioxidative Stress Effects.
    Oxidative medicine and cellular longevity, 2017, Volume: 2017

    Topics: Acute Lung Injury; Animals; Blotting, Western; DNA Helicases; Immunohistochemistry; Ketamine; Liver;

2017
Ketamine ameliorates ischemia-reperfusion injury after liver autotransplantation by suppressing activation of Kupffer cells in rats.
    Canadian journal of physiology and pharmacology, 2018, Volume: 96, Issue:9

    Topics: Animals; Apoptosis; Cytoprotection; Hepatocytes; Ketamine; Kupffer Cells; Liver Transplantation; Mal

2018
Effect of modulating the allosteric sites of N-methyl-D-aspartate receptors in ischemia-reperfusion induced acute kidney injury.
    The Journal of surgical research, 2013, Volume: 183, Issue:2

    Topics: Acute Kidney Injury; Allosteric Site; Animals; Catalase; Glutamic Acid; Glutathione; Ketamine; Kynur

2013
[Protective effect of low-dose ketamine against intestinal ischemia-reperfusion injury following carbon dioxide pneumoperitoneum in rats].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2013, Volume: 33, Issue:11

    Topics: Animals; Carbon Dioxide; Dose-Response Relationship, Drug; Fatty Acid-Binding Proteins; Interleukin-

2013
Low-dose ketamine pretreatment reduces oxidative damage and inflammatory response following CO2 pneumoperitoneum in rats.
    Clinical and investigative medicine. Medecine clinique et experimentale, 2014, Jun-01, Volume: 37, Issue:3

    Topics: Animals; Carbon Dioxide; Interleukin-6; Ketamine; Male; Malondialdehyde; Oxidative Stress; Pneumoper

2014
Preventive Treatment with Ketamine Attenuates the Ischaemia-Reperfusion Response in a Chronic Postischaemia Pain Model.
    Oxidative medicine and cellular longevity, 2015, Volume: 2015

    Topics: Analgesics; Animals; Behavior, Animal; Chronic Disease; Complex Regional Pain Syndromes; Disease Mod

2015
Ischemic Postconditioning and Subanesthetic S(+)-Ketamine Infusion: Effects on Renal Function and Histology in Rats.
    BioMed research international, 2015, Volume: 2015

    Topics: Animals; Blood Urea Nitrogen; Creatinine; Infusions, Intravenous; Ischemic Postconditioning; Ketamin

2015
Ketamine anesthesia reduces intestinal ischemia/reperfusion injury in rats.
    World journal of gastroenterology, 2008, Sep-07, Volume: 14, Issue:33

    Topics: Anesthetics, Dissociative; Animals; Disease Models, Animal; Gastrointestinal Motility; Intestinal Di

2008
Effects of ketamine on the balance of ions Ca2+, Mg2+, Cu2+ and Zn2+ in the ischemia-reperfusion affected spinal cord tissues in rabbits.
    Neurochemical research, 2009, Volume: 34, Issue:12

    Topics: Animals; Aorta, Abdominal; Calcium; Cations, Divalent; Constriction; Copper; Disease Models, Animal;

2009
The comparison of the effects of anesthetic doses of ketamine, propofol, and etomidate on ischemia-reperfusion injury in skeletal muscle.
    Fundamental & clinical pharmacology, 2010, Volume: 24, Issue:2

    Topics: Anesthetics, Dissociative; Anesthetics, Intravenous; Animals; Disease Models, Animal; Etomidate; Fem

2010
The effects of NMDA receptor antagonists over intestinal ischemia/reperfusion injury in rats.
    European journal of pharmacology, 2009, Oct-25, Volume: 621, Issue:1-3

    Topics: Alanine Transaminase; Animals; Antioxidants; Antithrombin III; Aspartate Aminotransferases; Biomarke

2009
Ketamine and the myenteric plexus in intestinal ischemia/reperfusion injury.
    Digestive diseases and sciences, 2010, Volume: 55, Issue:7

    Topics: Animals; Antithrombin III; Benzalkonium Compounds; Biomarkers; Disease Models, Animal; Immunohistoch

2010
Ischemia-reperfusion injury in skeletal muscle: comparison of the effects of subanesthetic doses of ketamine, propofol, and etomidate.
    The Journal of surgical research, 2010, Volume: 159, Issue:1

    Topics: Anesthetics; Animals; Catalase; Etomidate; Female; Glutathione Peroxidase; Ketamine; Malondialdehyde

2010
Thiopental improves renal ischemia-reperfusion injury.
    Renal failure, 2010, Volume: 32, Issue:3

    Topics: Anesthetics, Dissociative; Anesthetics, Intravenous; Animals; Antioxidants; Catalase; Etomidate; Fat

2010
[The effects of ketamine pretreated on cerebral edema and AQP4 expression after transient focal cerebral ischemia/reperfusion in rats].
    Zhonghua yi xue za zhi, 2010, Jun-15, Volume: 90, Issue:23

    Topics: Animals; Aquaporin 4; Brain; Brain Edema; Brain Ischemia; Ischemic Preconditioning; Ketamine; Male;

2010
Ketamine reduces intestinal injury and inflammatory cell infiltration after ischemia/reperfusion in rats.
    Surgery today, 2010, Volume: 40, Issue:11

    Topics: Analysis of Variance; Animals; Antithrombin III; Disease Models, Animal; Excitatory Amino Acid Antag

2010
[Effects of ischemia/reperfusion on the phosphotyrosine proteins contents in hippocampus].
    Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2001, Volume: 17, Issue:1

    Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Calcium Channels; Excitatory Amino Acid Antagonis

2001
Dexmedetomidine and S(+)-ketamine in ischemia and reperfusion injury in the rat kidney.
    Acta cirurgica brasileira, 2011, Volume: 26, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Anesthetics; Animals; Creatinine; Dexmedetomidine; Ketamine; K

2011
In vitro and in vivo responses of mucosa from the large colon of horses to ischemia and reperfusion.
    American journal of veterinary research, 2011, Volume: 72, Issue:7

    Topics: Analysis of Variance; Anesthetics, Intravenous; Animals; Colon; Diazepam; Electric Impedance; Horse

2011
A single small dose of ketamine prevents lung injury following hepatic ischemia-reperfusion in rabbits.
    Journal of the Chinese Medical Association : JCMA, 2011, Volume: 74, Issue:8

    Topics: Acute Lung Injury; Animals; Blood Pressure; Heart Rate; Immunohistochemistry; Intercellular Adhesion

2011
Ischemia-reperfusion injury of the mouse kidney.
    Methods in molecular biology (Clifton, N.J.), 2012, Volume: 886

    Topics: Anesthetics, General; Animals; Disease Models, Animal; Female; Hypnotics and Sedatives; Isoflurane;

2012
N-methyl-D-aspartate receptor and L-type voltage-gated Ca(2+) channel antagonists suppress the release of cytochrome c and the expression of procaspase-3 in rat hippocampus after global brain ischemia.
    Neuroscience letters, 2002, Aug-16, Volume: 328, Issue:3

    Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Calcium Channels, L-Type; Caspase 3; Caspase Inhi

2002
The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats.
    Anesthesia and analgesia, 2003, Volume: 96, Issue:2

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Apoptosis; Blood Gas Analy

2003
Modulation of IkappaB kinase autophosphorylation and activity following brain ischemia.
    Acta pharmacologica Sinica, 2003, Volume: 24, Issue:4

    Topics: Animals; Brain Ischemia; Excitatory Amino Acid Antagonists; Hippocampus; I-kappa B Kinase; Ketamine;

2003
[Effects of ketamine-midazolam anesthesia on focal cerebral ischemic injury in rats].
    Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2004, Volume: 24, Issue:12

    Topics: Adjuvants, Anesthesia; Anesthetics, Combined; Anesthetics, Dissociative; Animals; Apoptosis; Infarct

2004
The effect of ketamine on acute muscular ischaemia reperfusion in rats.
    European journal of anaesthesiology, 2005, Volume: 22, Issue:9

    Topics: Anesthetics, Dissociative; Animals; Female; Ischemia; Ketamine; Lipid Peroxidation; Lipid Peroxides;

2005
Inhibitory effect of ketamine on phosphorylation of the extracellular signal-regulated kinase 1/2 following brain ischemia and reperfusion in rats with hyperglycemia.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2007, Volume: 59, Issue:3-4

    Topics: Animals; Apoptosis; Brain Ischemia; Cerebral Cortex; Disease Models, Animal; Excitatory Amino Acid A

2007
Heat shock proteins following rat cerebral ischemic/reperfusion episode: effect of ketamine.
    Biochemistry and molecular biology international, 1994, Volume: 33, Issue:2

    Topics: Animals; Brain Ischemia; Cerebral Cortex; Disease Models, Animal; Hippocampus; HSP70 Heat-Shock Prot

1994
[Studies on the mechanism of protection of cultured neurous by ketamine anoxia/reoxygenation-induced injury].
    Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 1997, Volume: 13, Issue:2

    Topics: Animals; Cells, Cultured; Cerebral Cortex; Excitatory Amino Acid Antagonists; Fetus; Ketamine; L-Lac

1997
NMDA receptor activation results in tyrosine phosphorylation of NMDA receptor subunit 2A(NR2A) and interaction of Pyk2 and Src with NR2A after transient cerebral ischemia and reperfusion.
    Brain research, 2001, Aug-03, Volume: 909, Issue:1-2

    Topics: Animals; Brain Ischemia; Excitatory Amino Acid Antagonists; Focal Adhesion Kinase 2; Hippocampus; Im

2001
Mechanisms of regulation of tyrosine phosphorylation of NMDA receptor subunit 2B after cerebral ischemia/reperfusion.
    Acta pharmacologica Sinica, 2000, Volume: 21, Issue:8

    Topics: Animals; Calcium Channel Blockers; Genistein; Gerbillinae; Hippocampus; Ischemic Attack, Transient;

2000
Changes and mechanisms of protein-tyrosine kinase and protein-tyrosine phosphatase activities after brain ischemia/reperfusion.
    Acta pharmacologica Sinica, 2000, Volume: 21, Issue:8

    Topics: Animals; Calcium Channel Blockers; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Ketamine; N

2000
Effect of ketamine, dextromethorphan, and MK-801 on cochlear dysfunction induced by transient ischemia.
    The Annals of otology, rhinology, and laryngology, 2002, Volume: 111, Issue:1

    Topics: Action Potentials; Animals; Cochlea; Dextromethorphan; Dizocilpine Maleate; Guinea Pigs; Ketamine; R

2002
Nicotinamide and ketamine reduce infarct volume and DNA fragmentation in rats after brain ischemia and reperfusion.
    Neuroscience letters, 2002, Apr-12, Volume: 322, Issue:3

    Topics: Animals; Brain Ischemia; Cerebral Infarction; DNA Fragmentation; Excitatory Amino Acid Antagonists;

2002
Nuclear factor kappaB activation is mediated by NMDA and non-NMDA receptor and L-type voltage-gated Ca(2+) channel following severe global ischemia in rat hippocampus.
    Brain research, 2002, Apr-12, Volume: 933, Issue:1

    Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Calcium Channels, L-Type; Cytoplasm; Excitatory A

2002
[Effect of ischemia/reperfusion on the phosphorylation of synaptosomal tyrosine of hippocampus of Mongolian gerbils].
    Sheng li xue bao : [Acta physiologica Sinica], 2000, Volume: 52, Issue:2

    Topics: Animals; Brain Ischemia; Calcium Channels, L-Type; Gerbillinae; Hippocampus; Ketamine; Nifedipine; P

2000
Protecting the ischemic spinal cord during aortic clamping. The influence of anesthetics and hypothermia.
    Annals of surgery, 1992, Volume: 215, Issue:5

    Topics: Anesthetics; Animals; Aorta, Abdominal; Constriction; Halothane; Hypothermia, Induced; Intraoperativ

1992
Effects of taurine and ketamine on bovine retinal membrane lipid peroxidation.
    Neuroscience, 1991, Volume: 45, Issue:2

    Topics: Animals; Ascorbic Acid; Cadmium; Cadmium Chloride; Calcium; Cattle; Dextromethorphan; Female; Ischem

1991